Esophageal cancer (EC) is a global health challenge with high mortality rates.
The traditional TNM staging system is limited in its ability to provide accurate prognostic predictions.
This study aimed to investigate the utility of the C-reactive protein-albumin-lymphocyte (CALLY) index in the evaluation of mid- to long-term outcomes in patients undergoing esophagectomy.
